Changes of the Level of G Protein α-Subunit mRNA by Tolerance to and Withdrawal from Butorphanol
暂无分享,去创建一个
[1] I. Ho,et al. Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats , 1996, Psychopharmacology.
[2] R. Rockhold,et al. Increased locus coeruleus glutamate levels are associated with naloxone-precipitate withdrawal from butorphanol in the rat , 1995, Neurochemical Research.
[3] Seikwan Oh,et al. Changes of [3H]Muscimol Binding and GABAA Receptor β2-Subunit mRNA Level by Tolerance to and Withdrawal from Pentobarbital in Rats , 1999, Neurochemical Research.
[4] Seikwan Oh,et al. Changes in [3H]Forskolin Binding to Adenylate Cyclase and [3H]Phorbol Dibutyrate Binding to Protein Kinase C in Pentobarbital Tolerant/Dependent Rats , 1998, Neurochemical Research.
[5] K. Hoshi,et al. Role of NMDA Receptors in Pentobarbital Tolerance/Dependence , 1997, Neurochemical Research.
[6] E. Nestler. Molecular mechanisms of drug addiction [published erratum appears in J Neurosci 1992 Aug;12(8):following table of contents] , 1992, Neuropharmacology.
[7] P. Collas,et al. Signalling to the nucleus via A-kinase anchoring proteins. , 2004, Symposia of the Society for Experimental Biology.
[8] Hong Zhu,et al. Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids , 2001, Neurochemistry International.
[9] J. Thome,et al. Neural plasticity to stress and antidepressant treatment , 1999, Biological Psychiatry.
[10] C. Jang,et al. Withdrawal from butorphanol dependence alters binding of [ 3 H ]phorbol dibutyrate to protein kinase C, but not of [ 3 H ]forskolin to adenylate cyclase , 1999, Brain Research.
[11] K. Kuriyama,et al. Disappearance of gamma-aminobutyric acid (GABA)B receptor-mediated cAMP suppression in mouse cerebrum after chronic treatment with morphine. , 1996, Life sciences.
[12] G. Pasternak,et al. Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. , 1995, Trends in pharmacological sciences.
[13] Y. Tseng,et al. Crosstolerance between butorphanol and morphine in rats , 1994, Pharmacology Biochemistry and Behavior.
[14] P. Sánchez-Blázquez,et al. Antibodies directed against alpha subunits of Gi, Gx/z, GO and GS transducer proteins reduced the morphine withdrawal syndrome in mice. , 1994, Life sciences.
[15] G. Bell,et al. Molecular biology of opioid receptors , 1993, Trends in Neurosciences.
[16] I. Ho,et al. Effects of nor-binaltorphimine on butorphanol dependence. , 1993, European journal of pharmacology.
[17] T. Meyer,et al. Cyclic adenosine 3',5'-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. , 1993, Endocrine reviews.
[18] J. Mcculloch,et al. Focal increases in [3H]forskolin and [3H]phorbol 12,13-dibutyrate binding in the rat brain following lesions of the medial septum , 1993, Neuroscience Letters.
[19] G. Wardeh,et al. Adaptive changes in the number of Gs- and Gi-proteins underlie adenylyl cyclase sensitization in morphine-treated rat striatal neurons. , 1993, European journal of pharmacology.
[20] Bertil Hille,et al. G protein-coupled mechanisms and nervous signaling , 1992, Neuron.
[21] I. Ho,et al. The physical dependence liability of butorphanol: a comparative study with morphine. , 1991, European Journal of Pharmacology.
[22] E. Nestler,et al. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function , 1991, Brain Research.
[23] R. Schulz,et al. Chronic opiate receptor activation in vivo alters the level of g-protein subunits in guinea-pig myenteric plexus , 1989, Neuroscience.
[24] E. Nestler,et al. Regulation of G proteins by chronic morphine in the rat locus coeruleus , 1989, Brain Research.
[25] Kortaro Tanaka,et al. Autoradiographic analysis of second-messenger systems in the gerbil brain , 1988, Brain Research Bulletin.
[26] K. Gulya,et al. Central effects of the potent and highly selective μ opioid antagonist (CTOP) in mice , 1988 .
[27] K. Gulya,et al. Central effects of the potent and highly selective mu opioid antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) in mice. , 1988, European journal of pharmacology.
[28] L. Iversen,et al. Differences between high-affinity forskolin binding sites in dopamine-rich and other regions of rat brain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[29] J T Williams,et al. Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[30] G. Schultz,et al. The GTP-binding protein, Go9 regulates neuronal calcium channels , 1987, Nature.
[31] G. Aghajanian,et al. Pertussis toxin blocks the outward currents evoked by opiate and α2-agonists in locus coeruleus neurons , 1986, Brain Research.
[32] G. R. Brown. Stadol dependence: another case. , 1985, JAMA.
[33] J. N. Bowen,et al. A case of stadol dependence. , 1985, JAMA.
[34] J. Mccall,et al. [3H]U-69593 a highly selective ligand for the opioid κ receptor , 1985 .
[35] N. Neff,et al. gamma-aminobutyric acid B receptors are negatively coupled to adenylate cyclase in brain, and in the cerebellum these receptors may be associated with granule cells. , 1984, Molecular pharmacology.
[36] J. K. Chang,et al. Potent morphiceptin analogs: structure activity relationships and morphine-like activities. , 1983, The Journal of pharmacology and experimental therapeutics.
[37] T. Katada,et al. Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via alpha-adrenergic, cholinergic, and opiate receptors in neuroblastoma x glioma hybrid cells. , 1983, The Journal of biological chemistry.
[38] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[39] A. Block,et al. Angiotensin-induced contraction of the cat nictitating membrane. , 1971, European journal of pharmacology.